Histological studies of neuroprotective effects of Curcuma longa Linn. on neuronal loss induced by dexamethasone treatment in the rat hippocampus

Acta Histochemica

Volumn 116, Issue 8, 2014, Pages 1443-1453

  Issuriya, Acharaporn ^a   Kumarnsit, Ekkasit ^a   Wattanapiromsakul, Chatchai ^a   Vongvatcharanon, Uraporn ^a  

^a PRINCE OF SONGKLA UNIVERSITY   (Thailand)

Author keywords

Chronic stress; Cresyl violet; Curcuma longa; Dexamethasone; Glial fibrillary acidic protein; Hippocampus; Rats

Indexed keywords

CURCUMA LONGA EXTRACT; DEXAMETHASONE; GLIAL FIBRILLARY ACIDIC PROTEIN;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; ASTROCYTE; CELL DENSITY; CELL PROTECTION; CONTROLLED STUDY; DENTATE GYRUS; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; HIPPOCAMPAL CA1 REGION; HIPPOCAMPAL CA2 REGION; HIPPOCAMPAL CA3 REGION; HIPPOCAMPUS; HISTOLOGY; IMMUNOHISTOCHEMISTRY; MALE; NERVE CELL; NERVE CELL DEGENERATION; NEUROPROTECTION; NONHUMAN; RAT;

CURCUMA LONGA; RATTUS;

EID: 84919348834     PISSN: 00651281     EISSN: 16180372     Source Type: Journal    
DOI: 10.1016/j.acthis.2014.09.009     Document Type: Article

References (73)

1. Abbott N.J. Astrocyte-endothelial interactions and blood-brain barrier permeability. J Anat 2002, 200:629-638.
2. Abraham I.M., Harkany T., Horvath K.M., Luiten P.G. Action of glucocorticoids on survival of nerve cells: promoting neurodegeneration or neuroprotection. J Neuroendocrinol 2001, 13:749-760.
3. Ammon H.P., Wahl M.A. Pharmacology of Curcuma longa. Planta Med 1991, 57:1-7.
4. Araujo C.C., Leon L.L. Biological activities of Curcuma longa L. Mem Inst Oswaldo Cruz 2001, 96:723-728.
5. Arbel I., Kadar T., Silbermann M., Levy A. The effects of long-term corticosterone administration on hippocampal morphology and cognitive performance of middle-aged rats. Brain Res 1994, 657:227-235.
6. Banasr M., Chowdhury G.M., Terwilliger R., Newton S.S., Duman R.S., Behar K.L., et al. Glial pathology in an animal model of depression: reversal of stress-induced cellular, metabolic and behavioral deficits by the glutamate-modulating drug riluzole. Mol Psychiatry 2010, 15:501-511.
7. Barclay L.R., Vinqvist M.R., Mukai K., Goto H., Hashimoto Y., Tokunaga A., et al. On the antioxidant mechanism of curcumin: classical methods are needed to determine antioxidant mechanism and activity. Org Lett 2000, 2:2841-2843.
8. Claessens S.E., Belanoff J.K., Kanatsou S., Lucassen P.J., Champagne D.L., de Kloet E.R. Acute effects of neonatal dexamethasone treatment on proliferation and astrocyte immunoreactivity in hippocampus and corpus callosum: towards a rescue strategy. Brain Res 2012, 1482:1-12.
9. 2-induced renal epithelial (LLC-PK1) cell injury. Free Radic Biol Med 1998, 24:49-54.
10. Colombo J.A., Quinn B., Puissant V. Disruption of astroglial interlaminar processes in Alzheimer's disease. Brain Res Bull 2002, 58:235-242.
11. Conrad C.D., McLaughlin K.J., Harman J.S., Foltz C., Wieczorek L., Lightner E., et al. Chronic glucocorticoids increase hippocampal vulnerability to neurotoxicity under conditions that produce CA3 dendritic retraction but fail to impair spatial recognition memory. J Neurosci 2007, 27:8278-8285.
12. Cullen D.K., Simon C.M., LaPlaca M.C. Strain rate-dependent induction of reactive astrogliosis and cell death in three-dimensional neuronal-astrocytic co-cultures. Brain Res 2007, 1158:103-115.
13. Czeh B., Simon M., Schmelting B., Hiemke C., Fuchs E. Astroglial plasticity in the hippocampus is affected by chronic psychosocial stress and concomitant fluoxetine treatment. Neuropsychopharmacology 2006, 31:1616-1626.
14. Danilczuk Z., Sekita-Krzak J., Lupina T., Danilczuk M., Czerny K. Influence of dizocilpine (MK-801) on neurotoxic effect of dexamethasone: behavioral and histological studies. Acta Neurobiol Exp (Wars) 2006, 66:215-226.
15. Dong S., Zeng Q., Mitchell E.S., Xiu J., Duan Y., Li C., et al. Curcumin enhances neurogenesis and cognition in aged rats: implications for transcriptional interactions related to growth and synaptic plasticity. PLoS One 2012, 7:e31211.
16. Elliott E.M., Mattson M.P., Vanderklish P., Lynch G., Chang I., Sapolsky R.M. Corticosterone exacerbates kainate-induced alterations in hippocampal tau immunoreactivity and spectrin proteolysis in vivo. J Neurochem 1993, 61:57-67.
17. Esch T., Stefano G.B., Fricchione G.L., Benson H. The role of stress in neurodegenerative diseases and mental disorders. Neuro Endocrinol Lett 2002, 23:199-208.
18. Garcia-Alloza M., Borrelli L.A., Rozkalne A., Hyman B.T., Bacskai B.J. Curcumin labels amyloid pathology in vivo, disrupts existing plaques, and partially restores distorted neurites in an Alzheimer mouse model. J Neurochem 2007, 102:1095-1104.
19. Garrido C., Galluzzi L., Brunet M., Puig P.E., Didelot C., Kroemer G. Mechanisms of cytochrome c release from mitochondria. Cell Death Differ 2006, 13:1423-1433.
20. Hartmann A., Veldhuis J.D., Deuschle M., Standhardt H., Heuser I. Twenty-four hour cortisol release profiles in patients with Alzheimer's and Parkinson's disease compared to normal controls: ultradian secretory pulsatility and diurnal variation. Neurobiol Aging 1997, 18:285-289.
21. Hauger R.L., Millan M.A., Catt K.J., Aguilera G. Differential regulation of brain and pituitary corticotropin-releasing factor receptors by corticosterone. Endocrinology 1987, 120:1527-1533.
22. Haynes L.E., Griffiths M.R., Hyde R.E., Barber D.J., Mitchell I.J. Dexamethasone induces limited apoptosis and extensive sublethal damage to specific subregions of the striatum and hippocampus: implications for mood disorders. Neuroscience 2001, 104:57-69.
23. Heneka M.T., O'Banion M.K. Inflammatory processes in Alzheimer's disease. J Neuroimmunol 2007, 184:69-91.
24. Hibberd C., Yau J.L., Seckl J.R. Glucocorticoids and the ageing hippocampus. J Anat 2000, 4:553-562.
25. Hoenicka J. Genes in Alzheimer's disease. Rev Neurol 2006, 42:302-305.
26. Jacobson L., Sapolsky R. The role of the hippocampus in feedback regulation of the hypothalamic-pituitary-adrenocortical axis. Endocr Rev 1991, 12:118-134.
27. Jebelli J.D., Hooper C., Pocock J.M. Microglial p53 activation is detrimental to neuronal synapses during activation-induced inflammation: implications for neurodegeneration. Neurosci Lett 2014, 10.1016/j.neulet.2014.08.049.
28. Kordower J.H., Palfi S., Chen E.Y., Ma S.Y., Sendera T., Cochran E.J., et al. Clinicopathological findings following intraventricular glial-derived neurotrophic factor treatment in a patient with Parkinson's disease. Ann Neurol 1999, 46:419-424.
29. Kelloff G.J., Boone C.W., Crowell J.A., Steele V.E., Lubet R.A., Doody L.A., et al. New agents for cancer chemoprevention. J Cell Biochem Suppl 1996, 26:1-28.
30. Landfield P.W., Waymire J.C., Lynch G. Hippocampal aging and adrenocorticoids: quantitative correlations. Science 1978, 202:1098-1102.
31. Li W.Z., Li W.P., Yao Y.Y., Zhang W., Yin Y.Y., Wu G.C., et al. Glucocorticoids increase impairments in learning and memory due to elevated amyloid precursor protein expression and neuronal apoptosis in 12-month old mice. Eur J Pharmacol 2010, 628:108-115.
32. Liedtke W., Edelmann W., Bieri P.L., Chiu F.C., Cowan N.J., Kucherlapati R., et al. GFAP is necessary for the integrity of CNS white matter architecture and long-term maintenance of myelination. Neuron 1996, 17:607-615.
33. Lim G.P., Chu T., Yang F., Beech W., Frautschy S.A., Cole G.M. The curry spice curcumin reduces oxidative damage and amyloid pathology in an Alzheimer transgenic mouse. J Neurosci 2001, 21:8370-8377.
34. Maheshwari R.K., Singh A.K., Gaddipati J., Srimal R.C. Multiple biological activities of curcumin: a short review. Life Sci 2006, 78:2081-2087.
35. Maragakis N.J., Rothstein J.D. Mechanisms of disease: astrocytes in neurodegenerative disease. Nat Clin Pract Neurol 2006, 2:679-689.
36. McEwen B.S., Weiss J.M., Schwartz L.S. Selective retention of corticosterone by limbic structures in rat brain. Nature 1968, 220:911-912.
37. McIntosh L.J., Sapolsky R.M. Glucocorticoids increase the accumulation of reactive oxygen species and enhance adriamycin-induced toxicity in neuronal culture. Exp Neurol 1996, 141:201-206.
38. Mitchell I.J., Cooper A.J., Griffiths M.R., Barber D.J. Phencyclidine and corticosteroids induce apoptosis of a subpopulation of striatal neurons: a neural substrate for psychosis?. Neuroscience 1998, 84:489-501.
39. Moghaddam B., Bolinao M.L., Stein-Behrens B., Sapolsky R. Glucocorticoids mediate the stress-induced extracellular accumulation of glutamate. Brain Res 1994, 655:251-254.
40. Nichols N.R., Osterburg H.H., Masters J.N., Millar S.L., Finch C.E. Messenger RNA for glial fibrillary acidic protein is decreased in rat brain following acute and chronic corticosterone treatment. Brain Res Mol Brain Res 1990, 7:1-7.
41. Nichols N.R., Zieba M., Bye N. Do glucocorticoids contribute to brain aging?. Brain Res Brain Res Rev 2001, 37:273-286.
42. Notarianni E. Hypercortisolemia and glucocorticoid receptor-signaling insufficiency in Alzheimer' s disease initiation and development. Curr Alzheimer Res 2013, 10:714-731.
43. O'Brien J.T., Lloyd A., McKeith I., Gholkar A., Ferrier N. A longitudinal study of hippocampal volume, cortisol levels, and cognition in older depressed subjects. Am J Psychiatry 2004, 161:2081-2090.
44. O'Connor T.M., O'Halloran D.J., Shanahan F. The stress response and the hypothalamic-pituitary-adrenal axis: from molecule to melancholia. QJM 2000, 93:323-333.
45. Quax R.A., Manenschijn L., Koper J.W., Hazes J.M., Lamberts S.W., van Rossum E.F., et al. Glucocorticoid sensitivity in health and disease. Nat Rev Endocrinol 2013, 9:670-686.
46. Rappold P.M., Tieu K. Astrocytes and therapeutics for Parkinson's disease. Neurotherapeutics 2010, 7(4):413-423.
47. Reagan L.P., McEwen B.S. Controversies surrounding glucocorticoid-mediated cell death in the hippocampus. J Chem Neuroanat 1997, 13:149-167.
48. Reddy A.C., Lokesh B.R. Studies on spice principles as antioxidants in the inhibition of lipid peroxidation of rat liver microsomes. Mol Cell Biochem 1992, 111:117-124.
49. Reul J.M., de Kloet E.R. Two receptor systems for corticosterone in rat brain: microdistribution and differential occupation. Endocrinology 1985, 117:2505-2511.
50. Sapolsky R.M. Stress, glucocorticoids, and damage to the nervous system: the current state of confusion. Stress 1996, 1:1-19.
51. Sapolsky R.M., Krey L.C., McEwen B.S. Prolonged glucocorticoid exposure reduces hippocampal neuron number: implications for aging. J Neurosci 1985, 5:1222-1227.
52. Sekita-Krzak J., Zebrowska-Lupina I., Czerny K., Stepniewska M., Wrobel A. Neuroprotective effect of ACTH (4-9) in degeneration of hippocampal nerve cells caused by dexamethasone: morphological, immunocytochemical and ultrastructural studies. Acta Neurobiol Exp (Wars) 2003, 63:1-8.
53. Shukla P.K., Khanna V.K., Khan M.Y., Srimal R.C. Protective effect of curcumin against lead neurotoxicity in rat. Hum Exp Toxicol 2003, 22:653-658.
54. Sreejayan N., Rao M.N. Curcuminoids as potent inhibitors of lipid peroxidation. J Pharm Pharmacol 1994, 46:1013-1016.
55. Srinivasan S., Shariff M., Bartlett S.E. The role of the glucocorticoids in developing resilience to stress and addiction. Front Psychiatry 2013, 4:68.
56. Starkman M.N., Gebarski S.S., Berent S., Schteingart D.E. Hippocampal formation volume, memory dysfunction, and cortisol levels in patients with Cushing's syndrome. Biol Psychiatry 1992, 32:756-765.
57. Sumanont Y., Murakami Y., Tohda M., Vajragupta O., Watanabe H., Matsumoto K. Prevention of kainic acid-induced changes in nitric oxide level and neuronal cell damage in the rat hippocampus by manganese complexes of curcumin and diacetylcurcumin. Life Sci 2006, 78:1884-1891.
58. Szatkowski M., Attwell D. Triggering and execution of neuronal death in brain ischaemia: two phases of glutamate release by different mechanisms. Trends Neurosci 1994, 17:359-365.
59. Szymas J., Morkowski S., Tokarz F. Determination of the glial fibrillary acidic protein in human cerebrospinal fluid and in cyst fluid of brain tumors. Acta Neurochir (Wien) 1986, 83:144-150.
60. Tongjaroenbuangam W., Ruksee N., Chantiratikul P., Pakdeenarong N., Kongbuntad W., Govitrapong P. Neuroprotective effects of quercetin, rutin and okra (Abelmoschus esculentus Linn.) in dexamethasone-treated mice. Neurochem Int 2011, 59:677-685.
61. Unemura K., Kume T., Kondo M., Maeda Y., Izumi Y., Akaike A. Glucocorticoids decrease astrocyte numbers by reducing glucocorticoid receptor expression in vitro and in vivo. J Pharmacol Sci 2012, 119:30-39.
62. Vielkind U., Walencewicz A., Levine J.M., Bohn M.C. Type II glucocorticoid receptors are expressed in oligodendrocytes and astrocytes. J Neurosci Res 1990, 27:360-373.
63. Virgin C.E., Ha T.P., Packan D.R., Tombaugh G.C., Yang S.H., Horner H.C., et al. Glucocorticoids inhibit glucose transport and glutamate uptake in hippocampal astrocytes: implications for glucocorticoid neurotoxicity. J Neurochem 1991, 57:1422-1428.
64. Vongvatcharanon U., Mukem S., Udomukson W., Kumarnsit E., Vongvatcharanon S. Alcohol administration during adulthood induces alterations of parvalbumin and glial fibrillary acidic protein immunoreactivity in rat hippocampus and cingulated cortex. Acta Histochem 2010, 112:392-401.
65. Vyas S., Maatouk L. Contribution of glucocorticoids and glucocorticoid receptors to the regulation of neurodegenerative processes. CNS Neurol Disord Drug Targets 2013, 8:1175-1193.
66. Wada R., Tifft C.J., Proia R.L. Microglial activation and inflammatory reaction preceding neurodegeneration in Sandhoff disease. Int Congr Ser 2001, 1223:23-27.
67. Wahlstrom B., Blennow G. A study on the fate of curcumin in the rat. Acta Pharmacol Toxicol (Copenh) 1978, 43:86-92.
68. Winner B., Kohl Z., Gage F.H. Neurodegenerative disease and adult neurogenesis. Eur J Neurosci 2011, 33:1139-1151.
69. Woolley C.S., Gould E., McEwen B.S. Exposure to excess glucocorticoids alters dendritic morphology of adult hippocampal pyramidal neurons. Brain Res 1990, 531:225-231.
70. Xu Y., Ku B., Cui L., Li X., Barish P.A., Foster T.C., et al. Curcumin reverses impaired hippocampal neurogenesis and increases serotonin receptor 1A mRNA and brain-derived neurotrophic factor expression in chronically stressed rats. Brain Res 2007, 1162:9-18.
71. Yu I.T., Lee S.H., Lee Y.S., Son H. Differential effects of corticosterone and dexamethasone on hippocampal neurogenesis in vitro. Biochem Biophys Res Commun 2004, 317:484-490.
72. Yu S., Holsboer F., Almeida O.F. Neuronal actions of glucocorticoids: focus on depression. J Steroid Biochem Mol Biol 2008, 108:300-309.
73. Yu S., Yang S., Holsboer F., Sousa N., Almeida O.F. Glucocorticoid regulation of astrocytic fate and function. PLoS One 2011, 6:e22419.